STAGES OF DEVELOPMENT

Cellceutix has met primary endpoints in all trials completed to date. The company’s successful advancement of its compounds, bench-to-bedside, is indicative of the strength of its science and the capabilities of management. The further a drug candidate progresses through the FDA's drug review process, the greater the likelihood of approval.